Ascend Wellness Holdings (AAWH) Change in Acquisitions & Divestments (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Change in Acquisitions & Divestments came in at $3.0 million in Q1 2026, up 3591.46% year-on-year from $82000.0 in Q1 2025, and up 3591.46% quarter-over-quarter from $82000.0 in Q4 2025.
Ascend Wellness Holdings (AAWH) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments rose 3591.46% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $7.4 million, a 2154.43% increase from a year earlier, with the FY2025 full-year figure at $4.4 million, down 47.47% from the prior year.
- Change in Acquisitions & Divestments rose to $3.0 million in Q1 2026 per AAWH's latest filing, from $82000.0 in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $8.2 million in Q1 2024 and bottomed at $81000.0 in Q3 2022.
- The 5-year median for Change in Acquisitions & Divestments is $82000.0 (2022), against an average of $972647.1.
- Across the five-year window, Change in Acquisitions & Divestments soared 9878.05% in 2024 and plunged 99.0% in 2025, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $82000.0 in 2022, then changed by 0.0% to $82000.0 in 2023, then changed by 0.0% to $82000.0 in 2024, then changed by 0.0% to $82000.0 in 2025, then soared by 3591.46% to $3.0 million in 2026.
- Per Business Quant, the three latest AAWH Change in Acquisitions & Divestments figures stand at $3.0 million (Q1 2026), $82000.0 (Q4 2025), and $4.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Ascend Wellness Holdings | 78.95 Mn | 18.03 Mn | 44.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.03 Mn |
| Mar 31, 2026 | 3.03 Mn |
| Dec 31, 2025 | 82,000.00 |
| Dec 31, 2025 | 82,000.00 |
| Sep 30, 2025 | 4.18 Mn |
| Sep 30, 2025 | 4.18 Mn |
| Jun 30, 2025 | 82,000.00 |
| Jun 30, 2025 | 82,000.00 |
| Mar 31, 2025 | 82,000.00 |
| Mar 31, 2025 | 82,000.00 |
| Dec 31, 2024 | 82,000.00 |
| Dec 31, 2024 | 82,000.00 |
| Sep 30, 2024 | 81,000.00 |
| Sep 30, 2024 | 81,000.00 |
| Jun 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 82,000.00 |
| Mar 31, 2024 | 8.18 Mn |
| Mar 31, 2024 | 8.18 Mn |
| Dec 31, 2023 | 82,000.00 |
| Dec 31, 2023 | 82,000.00 |